Home > Products > CA19-9 & CD3
> Recombinant Anti-CA19-9 x Anti-CD3 Bispecific Antibody (scIgG)
Recombinant Anti-CA19-9 x Anti-CD3 Bispecific Antibody (scIgG) (CAT#: SCIGG-026)
Recombinant Anti-CA19-9 x Anti-CD3 Bispecific Antibody (scIgG) is designed to be expressed as two chains, each chain has the same units with their parental IgG antibodies, anti-CA19-9 and anti-CD3 IgGs. The two chains form heterodimer via Fc KIH technology. This BsAb can retarget T cells to tumor cells. It is designed for the research of Ovarian cancer; Pancreatic cancer; Gastric cancer therapy.
There are currently no customer reviews or questions for Recombinant Anti-CA19-9 x Anti-CD3 Bispecific Antibody (scIgG) (SCIGG-026). Click the button below to contact us or submit your feedback about this product.